(Q39689968)

14 September 2017

Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions (English)

1 reference

14 September 2017

1 reference

G Ahlin

1

1 reference

14 September 2017

L Chen

2

1 reference

14 September 2017

L Lazorova

3

1 reference

14 September 2017

Y Chen

4

1 reference

14 September 2017

A G Ianculescu

5

1 reference

14 September 2017

R L Davis

6

1 reference

14 September 2017

K M Giacomini

7

1 reference

14 September 2017

P Artursson

8

1 reference

14 September 2017

22 June 2010

1 reference

The Pharmacogenomics Journal

14 September 2017

1 reference

14 September 2017

11

1 reference

14 September 2017

400-411

1 reference

14 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/tpj.2010.54

14 September 2017

0 references

cites work

Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Cloning and characterization of two human polyspecific organic cation transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Regulation of the human organic cation transporter hOCT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Clinical pharmacokinetics of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Comparison of the pharmacokinetics of glipizide and glibenclamide in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

The pharmacokinetics of pioglitazone in patients with impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Crystal structural analysis of human serum albumin complexed with hemin and fatty acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Finishing the euchromatic sequence of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Impact of extracellular protein binding on passive and active drug transport across Caco-2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Cysteine accessibility in the hydrophilic cleft of human organic cation transporter 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

A global drug inhibition pattern for the human ATP-binding cassette transporter breast cancer resistance protein (ABCG2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--toward a consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

A molecular functional study on the interactions of drugs with plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

A human transporter protein that mediates the final excretion step for toxic organic cations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Polymorphism in human organic cation transporters and metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Metformin transport by renal basolateral organic cation transporter hOCT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

Bioequivalence evaluation of two formulations of doxazosin tablet in healthy thai male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.54

21 January 2018

Identifiers

DOI

10.1038/TPJ.2010.54

1 reference

release_zjtr6repwbg65docfzvylapica

14 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zjtr6repwbg65docfzvylapica

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference